Clinical Trials Logo

Clinical Trial Summary

Goal directed fluid therapy (GDFT) or "Personalized fluid therapy" may benefit high-risk surgical patients but these strategies are infrequently implemented. It has also been shown that without any goal or protocol for fluid resuscitation, large inter- and intra-provider variability exist that have been correlated with poor patient outcomes. Recently, an "Assisted Fluid Management" (AFM) system has been developed to help ease some of the work associated with GDFT protocol implementation. The AFM system may help increase GDFT protocol adherence while leaving direction and guidance in the hands of the care providers. This artificial intelligence-based system can suggest administration of fluid boluses, analyse the hemodynamic effects of the bolus, and continually re-assess the patient for further fluid requirements. To date, there are no large outcome study using this AFM system. The primary objective of this trial is thus to evaluate the impact of this AFM system to guide fluid bolus administration on a composite of major postoperative complications in high-risk patients undergoing high-risk abdominal surgery.


Clinical Trial Description

Many trials have indicated that goal-directed fluid therapy (GDFT) strategies or more recently "personalized fluid therapy" may benefit high-risk surgical patients but these strategies are infrequently implemented. It has also been shown that without any goal or protocol for fluid resuscitation, large inter- and intra-provider variability exist that have been correlated with poor patient outcomes. Even under ideal study conditions, strict adherence to GDFT protocols is hampered by the workload and concentration required for consistent implementation. Hemodynamic monitors and protocols alone do not enable optimal fluid titration to be provided consistently to all patients - there must also be appropriate and timely interpretation and intervention. To address this problem of consistency and protocol adherence, a decision support system, "Assisted Fluid Management" (AFM), has been developed to help ease some of the work associated with GDFT protocol implementation. The AFM system (released on the European market in March 2017) may help increase GDFT protocol adherence while leaving direction and guidance in the hands of the care providers. This artificial intelligence-based system can suggest administration of fluid boluses, analyse the hemodynamic effects of the bolus, and continually re-assess the patient for further fluid requirements. This system was recently implemented in a before-and-after study in a Belgian academic hospital, where the authors reported that the implementation of this AFM software system allowed a better adherence to the GDFT algorithm. However, as this was a pilot study with a small number of patients, the study was not powered to demonstrate a beneficial effect on the incidence of postoperative complications. More recently, a group from the Cleveland Clinic demonstrated that using AFM system resulted in more boluses being effective when compared to the administration of boluses without AFM support. There are no randomized controlled studies to date comparing this AFM system to standard of care on patient outcome. We therefore aim to conduct a multicenter stepped-wedge, cluster-randomized trial involving patients undergoing high risk abdominal surgery to compare a GDFT strategy guided by the AFM system with usual care. A stepped wedge, cluster-randomized trial approach was chosen in which clusters will be randomized to commence the intervention at different times following an initial control period in which outcomes will be measured for usual care. So, each center (cluster) began in the control phase and transitioned to the intervention phase at a randomly assigned time (wedge). The order in which each center will move from control to intervention phase will be randomly allocated by a computer algorithm performed by the study statistician. We selected cluster randomization rather than randomization of individual patients because the control group could be very different among centers (from GDFT strategy using a flow monitoring to GDFT with a written protocol to no clear strategy (use of an arterial line only without any advanced monitoring). Interestingly, this approach also decreases the Hawthorne effect which has been shown to decrease the incidence rate of the primary outcome in recent randomized trials because clinicians know that their patients are included in a research protocol. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06011187
Study type Interventional
Source Assistance Publique - Hôpitaux de Paris
Contact ALEXANDRE JOOSTEN, MD PhD
Phone +33145213441
Email joosten-alexandre@hotmail.com
Status Recruiting
Phase N/A
Start date February 1, 2024
Completion date December 30, 2026

See also
  Status Clinical Trial Phase
Completed NCT05268419 - Efficacy and Safety of Ethanol Inhalation on COVID-19 Treatment (a Clinical Trial Study) Phase 3
Completed NCT03251573 - The Cohort Study of Cognitive Impairment in Chinese Hemodialysis Patients
Completed NCT04238806 - Desflurane,Brain Natriuretic Peptide and Cardiac Surgery N/A
Enrolling by invitation NCT05161104 - A Multicenter Cross-sectional Study of Cardiac Ultrasound Phenotypes in Patients With Sepsis
Recruiting NCT03893136 - The Registry Study of Takayasu Arteritis in East China
Recruiting NCT03305276 - Observatory on Impact of Life Styles on Health Outcomes N/A
Recruiting NCT04963530 - Enamel Wear Evaluation in Patients With Different Ceramic Restorations N/A
Withdrawn NCT03022877 - Acute and Chronic Protective Effects of Peri-interventional Administration of Levosimendan in ST Elevation Myocardial Infarctions N/A
Completed NCT02041403 - RENAL RESISTIVE INDEX POST-OPERATIVE COMPLICATIONS IN MAJOR SURGERY? N/A
Withdrawn NCT01343069 - Safety Improvement and Checklist Application N/A
Withdrawn NCT01356446 - Checklist Application and Mortality N/A
Not yet recruiting NCT04918953 - Factors Influencing the Prognosis of Olfactory Dysfunction After Upper Sensation Phase 2
Completed NCT03765372 - Evaluation of BIomarkers for POstoperative Complications in Non-cardiac Surgery Patients
Completed NCT05133960 - The Turkish Version of the Activity Diversity Questionnaire
Completed NCT03247049 - Prognosis in Intracerebral Hemorrhage. The ICHCat Score in Primary Care. N/A
Recruiting NCT03143595 - Clinical Outcomes in Elderly Patients With Preoperative Cognitive Dysfunction N/A
Not yet recruiting NCT06087939 - Outcome and Predictors of Mortality of Patients on Prolonged Mechanical Ventilation
Recruiting NCT01755819 - Outcome and Tunnel Widening After ACL Reconstruction: Comparison of Aperture and Cortical Fixation N/A
Recruiting NCT04979741 - Recovery After Intensive Care Study
Completed NCT03609762 - Effectiveness of Routine Measurement of HRQOL N/A